Loading…
CIK 0001964437 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("saturn-v-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $87.5M | 16.1%Prev: 14.9% | 649,179 SH | Increased-152,045 SH |
| ALUMIS INC | COM | $30.6M | 5.6% | 3,135,953 SH | New |
| AMYLYX PHARMACEUTICALS INC | COM | $54.3M | 10.0%Prev: 13.7% | 4,496,487 SH | Decreased-108,391 SH |
| CELCUITY INC | COM | $31.6M | 5.8%Prev: 5.1% | 317,095 SH | Increased-156,733 SH |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $7.1M | 1.3%Prev: 3.9% | 282,692 SH | Decreased-451,847 SH |
| COGENT BIOSCIENCES INC | COM | $43.2M | 7.9%Prev: 6.4% | 1,217,064 SH | Increased-807,977 SH |
| DISC MEDICINE INC | COM | $23.7M | 4.3%Prev: 4.9% | 298,429 SH | Increased-42,468 SH |
| DYNE THERAPEUTICS INC | COM | $35.0M | 6.4%Prev: 7.4% | 1,788,616 SH | Increased-885,853 SH |
| IMMIX BIOPHARMA INC | COM | $15.7M | 2.9% | 2,999,169 SH | New |
| INHIBIKASE THERAPEUTICS INC | COM NEW | $7.9M | 1.5% | 3,856,799 SH | New |
| INVENTIVA SA | ADS | $1.3M | 0.2% | 283,166 SH | New |
| INVIVYD INC | COM | $19.1M | 3.5% | 7,735,386 SH | New |
| JAZZ PHARMACEUTICALS PLC | SHS USD | $42.2M | 7.7%Prev: 8.7% | 248,070 SH | Increased-52,540 SH |
| MONOPAR THERAPEUTICS INC | COM NEW | $21.3M | 3.9%Prev: 2.8% | 325,701 SH | Increased+170,331 SH |
| OCULAR THERAPEUTIX INC | COM | $18.3M | 3.4%Prev: 3.0% | 1,504,880 SH | Increased+353,194 SH |
| OCULIS HOLDING AG | ORDINARY SHARES | $10.3M | 1.9% | 516,761 SH | New |
| OVID THERAPEUTICS INC | COM | $4.1M | 0.7% | 2,500,000 SH | New |
| PHARVARIS N V | COM | $31.6M | 5.8%Prev: 4.8% | 1,140,033 SH | Increased+253,701 SH |
| VAXCYTE INC | COM | $36.9M | 6.8%Prev: 6.2% | 798,940 SH | Increased+10,499 SH |
| X4 PHARMACEUTICALS INC | COM NEW | $23.2M | 4.3% | 5,800,530 SH | New |
| 13F-HR |
| 0001964437-26-000012 |
| $697.5M |
| View |
| Aug 13, 2025 | Q2 2025 | 13F-HR | 0001964437-25-000008 | $246.8M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001964437-26-000005 | $552.2M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001964437-25-000005 | $198.2M | View |